Drug Type Small molecule drug |
Synonyms S-allyl L-cysteine, NSC-96449, PMK S005 + [3] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC6H11NO2S |
InChIKeyZFAHNWWNDFHPOH-YFKPBYRVSA-N |
CAS Registry21593-77-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peptic Ulcer | Phase 2 | South Korea | 24 Nov 2014 | |
Recurrent ulcer | Phase 2 | South Korea | 24 Nov 2014 | |
Gastritis | Phase 1 | United States | 01 Dec 2012 | |
Stomach Ulcer | Phase 1 | United States | 01 Dec 2012 | |
Age Related Macular Degeneration | Preclinical | Canada | 22 Jan 2024 | |
Age Related Macular Degeneration | Preclinical | United Kingdom | 22 Jan 2024 | |
Diabetic Retinopathy | Preclinical | Canada | 22 Jan 2024 | |
Diabetic Retinopathy | Preclinical | United Kingdom | 22 Jan 2024 | |
Glaucoma | Preclinical | Canada | 22 Jan 2024 | |
Glaucoma | Preclinical | United Kingdom | 22 Jan 2024 |